Maximum population-level penetrance figures for C9orf72-related MND/FTD are around 33%, meaning that at least two-thirds of individuals carrying the repeat expansion in the general population will not go on to develop the disease. The gene discussed is C9orf72; the disease is mild neurocognitive disorder.